Products authorised through the same biocidal product authorisation procedure have their own clusters. This allows you to track all the market areas where a specific product is placed as well as all the trade names under which a product is marketed. The authorisation is published together with the related mutual recognitions in the other Member States where the biocidal product has been allowed on the market.īiocidal products are presented as groups of authorisations, product clusters, where mutual recognitions (extensions of the national product authorisation to other markets areas) are presented with their reference authorisations. National authorisations: These biocidal products are authorised in specific EU countries. Union authorisations: These biocidal products are allowed to be placed on the market throughout the entire EU/EEA and Switzerland. The authorisation is published together with the related notifications for placing a biocidal product on the market. Simplified authorisations: These biocidal products have a more favourable environmental or human and animal health profile and therefore follow a simpler procedure. Information from three authorisation types is available: Product details, for example use information, such as target organism and application method of a product, or hazard and precautionary statements). The active substance in the product (includes the option to search by active substances known to be candidates for substitution) Īuthorisation data, (for example authorisation holder or authorisation number) You can search for biocidal products with: However, products that were on the market before 2000 can continue to be sold while the authorities are evaluating the active substances they contain. Here you can find information on biocidal products authorised on the EU/EEA market, in accordance with the Biocidal Products Directive (Directive 98/8/EC) or the Biocidal Products Regulation (Regulation (EU) No 528/2012).Īll biocidal products containing approved active substances are evaluated for safety and efficacy before they are allowed to be sold in the EU.